Literature DB >> 27383883

Application of instrumented nanoindentation in preformulation studies of pharmaceutical active ingredients and excipients.

Mateja Egart, Biljana Janković, Stane Srčič.   

Abstract

Nanoindentation allows quantitative determination of a material's response to stress such as elastic and plastic deformation or fracture tendency. Key instruments that have enabled great advances in nanomechanical studies are the instrumented nanoindenter and atomic force microscopy. The versatility of these instruments lies in their capability to measure local mechanical response, in very small volumes and depths, while monitoring time, displacement and force with high accuracy and precision. This review highlights the application of nanoindentation for mechanical characterization of pharmaceutical materials in the preformulation phase (primary investigation of crystalline active ingredients and excipients). With nanoindentation, mechanical response can be assessed with respect to crystal structure. The technique is valuable for mechanical screening of a material at an early development phase in order to predict and better control the processes in which a material is exposed to stress such as milling and compression.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27383883     DOI: 10.1515/acph-2016-0032

Source DB:  PubMed          Journal:  Acta Pharm        ISSN: 1330-0075            Impact factor:   2.230


  2 in total

1.  Mechanical Characterization of Pharmaceutical Powders by Nanoindentation and Correlation with Their Behavior during Grinding.

Authors:  Laura Baraldi; Davide De Angelis; Roberto Bosi; Roberto Pennini; Irene Bassanetti; Andrea Benassi; Guido Enrico Bellazzi
Journal:  Pharmaceutics       Date:  2022-05-27       Impact factor: 6.525

2.  The Role of Cocrystallization-Mediated Altered Crystallographic Properties on the Tabletability of Rivaroxaban and Malonic Acid.

Authors:  Dnyaneshwar P Kale; Vibha Puri; Amit Kumar; Navin Kumar; Arvind K Bansal
Journal:  Pharmaceutics       Date:  2020-06-12       Impact factor: 6.321

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.